A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes
Clinical trial NCT03689374 · COMPLETED
Trial details
- NCT number
- NCT03689374
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2021-02-22
- Enrollment
- 2274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.